[Reexamination of multimodal treatment in patient with cancer].
Matsuoka
H
H
Clinical Research Institute, National Kyushu Cancer Center.
Furusawa
M
M
Morita
M
M
Kakeji
Y
Y
Kounoe
T
T
Seo
Y
Y
Saito
T
T
Tomoda
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000494:pharmacology; D003131:Combined Modality Therapy; D004354:Drug Screening Assays, Antitumor; D005047:Etoposide / Q000494:pharmacology; D005472:Fluorouracil / Q000494:pharmacology; D006801:Humans; D006979:Hyperthermia, Induced; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000528:radiation effects
D005047:Etoposide; D002945:Cisplatin; D005472:Fluorouracil